Building a size on purpose
Once you know the size you want, you make it. The general act of breaking solids into smaller pieces is comminution; the practical machinery for it is milling. A hammer mill smashes coarse lumps down to tens of micrometres, while a fluid-energy (jet) mill collides particles against each other in a high-speed air stream to reach the single-digit micrometres needed for inhalation. Each step raises specific surface area and narrows the path to a target dissolution rate.
Surface meets dissolution: Noyes-Whitney
Guide 1 said more surface dissolves faster; the Noyes-Whitney equation makes that exact. It states that the rate a solid dissolves rises in proportion to its surface area A and to the gap between saturation solubility and the concentration already dissolved. Of all its terms, surface area is the one micromeritics controls — which is precisely why we mill poorly soluble drugs.
Noyes-Whitney — effect of cutting particle size
dC/dt = (D · A / h) · (Cs − C)
D = diffusion coefficient (set by drug & medium)
A = total surface area of solid ← micromeritics controls this
h = diffusion-layer thickness
Cs = saturation solubility, C = bulk concentration
Surface area per gram scales as ~1/diameter, so:
Mill from d = 50 µm → d = 5 µm (10× finer)
Surface area A increases ~10×
→ initial dissolution rate dC/dt increases ~10×
(all else equal, under sink conditions C ≪ Cs)
Takeaway: shrinking particle size is the formulator's
main lever on A, hence on dissolution rate.Pushed to its limit, this logic gives the nanocrystal: a drug milled to a few hundred nanometres, where the colossal surface area can lift the apparent dissolution and absorption of an otherwise hopeless compound. The trade-off is that such fine, high-energy particles want to clump and grow, so they must be stabilised with surfactants or polymers.
The inhalation frontier
Nowhere is particle size more brutally decisive than in the lung. Whether an inhaled particle reaches the deep airways or crashes in the throat depends not on its geometric diameter but on its aerodynamic diameter — the diameter of a unit-density sphere that settles at the same speed, which blends size, shape, and density into one flight-relevant number. The therapeutic window is narrow: particles around 1–5 µm deposit in the lung, larger ones strike the mouth and throat, and much smaller ones are simply breathed back out.
This is where everything in this track converges. A dry-powder inhaler holds micronised drug — far too fine and cohesive to flow on its own — gently adhered to large lactose carrier particles. The patient's breath must shear the drug off the carrier so the tiny active flies to the lung while the coarse carrier deposits harmlessly in the throat. Size for deposition, surface forces for adhesion, flow for metering: micromeritics is the whole product.